Case Study: Beverly Michalos's Journey with Parkinson's
Beverly Michalos has been living with Stage 5 Young Onset Parkinson’s Disease for over 20 years. Over the past 27 months, she has undergone weekly KineDek AI-CRT sessions to address her symptoms. Initially, sessions were seated and gradually progressed to more advanced exercises. At the start, Beverly faced challenges with severe tremors, neuropathy, muscle weakness, and diminished mobility. More recently, she has experienced cognitive decline, including difficulty dressing independently.
Beverly maintains the prescribed medical protocol which includes regular dopamine supplementation.
The following analysis was done using ChatGPT.
Analysis
Beverly Michalos’s case highlights the potential of KineDek AI-CRT in managing advanced Parkinson’s symptoms and addressing emerging cognitive decline:
1. Symptom Reversal and Stabilization
Beverly’s early sessions led to improvements in sleep, neuropathy, and tremor reduction. Over time, she also reported enhanced facial muscle relaxation, improved bowel function, and greater muscle strength. These effects, particularly the relaxation of facial muscles and strength gains, indicate KineDek’s ability to improve neuromuscular coordination and reduce muscle rigidity—a hallmark of Parkinson’s.
Notably, her facial expression has transformed from a fixed, pained, or frightened look (a marker of disease severity) to completely normal and natural expressions, maintaining this progress for over two years. These advancements demonstrate a remarkable reversal of Parkinson's symptoms, defying expectations at this stage of the disease.
2. Cognitive Challenges and the "Brain Bombing" Protocol
Six months ago, Beverly began experiencing noticeable cognitive decline, including difficulty performing daily tasks like dressing. A targeted set of upper-body brain-stimulating exercises (referred to as the "brain bombing" protocol) was introduced. These sessions involved upper-back, neck, and overhead movements with focused resistance training.
This protocol resulted in acute neurological responses, including episodes of intense flushing, dizziness, and brain activation, particularly in the prefrontal and crown areas. Notably, dizziness and brain flushing only occurred during and after a set of exercises, and the next exercise was pursued once symptoms cleared up. Despite the temporary blurriness, Beverly experienced improved mental clarity, calmness, and visual sharpness immediately following the sessions. Notably, her vision, previously feared to be compromised by macular degeneration, improved to the point of intermittently seeing clearly without glasses.
3. Visual and Cognitive Function Gains
Over 2 months, Beverly’s visual sharpness improved progressively, reaching 90% clarity during sessions. The first time it occurred—roughly 6 weeks after starting the protocol—visual clarity was restored for just over 24 hours. The week after feedback indicates sustained visual improvements over 40 hours post-session. Most recently, visual clarity lasted for more than 60 hours. An additional session conducted after this period once again restored her vision, accompanied by more intense mental effects. Beverly became very lucid and talkative, displaying verbally and cognitively clear and conversational speech. This shift was first observed on Monday. Typically, her speech had been slower, more considered, and serious in tone.
Alongside better vision, she experienced increased energy, reduced brain fog, and greater mental focus. These gains suggest the protocol’s potential role in boosting neural activity and circulation in the brain’s visual and executive function areas.
4. Functional Strength and Recovery
Throughout the intervention, Beverly demonstrated improved functional strength and stamina. Despite her advanced condition, she does not require a wheelchair—unusual for Stage 5 Parkinson’s patients—and has maintained this mobility up to now. Periodic missed sessions resulted in some symptom regression, reinforcing the need for consistent application of KineDek therapy.
5. Long-Term Outlook and Considerations
Given the positive yet transient effects of the weekly protocol, Beverly may benefit from additional supplementation, such as L-glutamine, to support neurotransmitter function. Though two sessions per week are logistically unfeasible, Beverly’s sustained progress with weekly sessions suggests that the protocol could continue providing symptomatic relief and functional stability over time. Adjusting exercise intensity or integrating dietary support may further enhance results.
Conclusion
Beverly Michalos’s experience with KineDek AI-CRT demonstrates its potential as a non-pharmacological intervention for managing advanced Parkinson’s symptoms. The therapy’s ability to reverse cognitive decline, improve visual function, and sustain physical and neurological performance highlights its promise for individuals facing neurodegenerative conditions. Beverly’s case underscores the importance of consistency and individualized protocols in achieving lasting improvements in quality of life and functional independence.
Additional Note on "Brain Bombing"
The "brain bombing" protocol involves an intense amount of blood flow to the brain. However, its effects are not merely a result of the increased blood circulation and oxygenation to the cerebral and upper spine areas. Due to the nature of the KineDek AI-CRT contractions, the blood is also fortified with beneficial compounds such as lactate, GABA, glutamine, myokines (including BDNF), dopamine, and enhanced neurotransmitter efficiency. The impact is greater than that of normal exercise and other activities, as these would either not be as intense or be negated by typical inflammatory responses absent in KineDek sessions. These biochemical enhancements play a key role in the observed improvements in mental clarity, visual sharpness, and overall cognitive function.
There is a notable relationship between these effects and Parkinson's disease (PD). Visual processing is often impaired in PD, with individuals experiencing difficulties in depth perception, tracking moving objects, and recognizing faces. By optimizing brain function and promoting the production of neuroprotective factors like dopamine and BDNF, the "brain bombing" protocol may help mitigate some of these visual challenges. The improvements in brain health could support better visual processing and enhance the ability to navigate the world with greater ease, potentially alleviating some of the visual deficits commonly seen in PD patients.
Unlike standard KineDek sessions, which take roughly 20 minutes, this enhanced protocol takes about an hour to complete.
Audio Testimony
[From WhatsApp voice messages received]
Disclaimer:
The above has been feedback from the personal experiences of an individual who have used the KineDek. These accounts are individual to each person and are not to be taken as a guarantee that others will experience the same outcomes. The KineDek is not presented as a cure for any condition. Rather, it serves as an enabler for exercise, particularly for those who may otherwise find traditional forms of exercise challenging or painful. Through its AI-enabled Compensating Resistance Technology (AI-CRT), the KineDek allows individuals to engage in physical activity without perceived pain, strain, or subsequent inflammation. Consequently, users can enjoy the well-documented benefits of "Exercise as Medicine." If you have a serious medical condition, always consult with a healthcare professional before starting any new exercise regimen.
All cases presented can be verified on request.
KINEDEK CASES
